Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A series of cases. Rev Alerg Mex [Internet]. 2019 Jun. 27 [cited 2026 Sep. 23];66(3):282-91. Available from: https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/401